Lakewood-Amedex Biotherapeutics Inc. - 8-K Filing

Lakewood-Amedex Biotherapeutics Inc. released an investor presentation on July 15, 2026 highlighting its Bisphosphocin® compounds and Nu-3 clinical development for infected diabetic foot ulcers. (Items: 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Exhibits (d) Exhibits Exhibit Number Description 99)

SEC EDGAR · July 15, 2026, 20:16 UTC

Tickers: $LABT

Read the full article at SEC EDGAR

More Regulatory news

Eyeonix AIQ, Inc. - 10-Q Filing SEC EDGAR · November 12, 2026, 18:03 UTC
Canterbury Park Holding Corp - 10-Q Filing SEC EDGAR · November 12, 2026, 18:00 UTC
TRANSCONTINENTAL REALTY INVESTORS INC - 8-K Filing SEC EDGAR · November 12, 2026, 17:47 UTC
Bluerock Homes Trust, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 17:44 UTC
Circle Energy, Inc./NV - 10-Q Filing SEC EDGAR · November 12, 2026, 17:44 UTC
AMERICAN REALTY INVESTORS INC - 8-K Filing SEC EDGAR · November 12, 2026, 17:42 UTC
INCOME OPPORTUNITY REALTY INVESTORS INC /TX/ - 8-K Filing SEC EDGAR · November 12, 2026, 17:42 UTC
INCOME OPPORTUNITY REALTY INVESTORS INC /TX/ - 10-Q Filing SEC EDGAR · November 12, 2026, 17:35 UTC
TRANSCONTINENTAL REALTY INVESTORS INC - 10-Q Filing SEC EDGAR · November 12, 2026, 17:33 UTC
AMERICAN REALTY INVESTORS INC - 10-Q Filing SEC EDGAR · November 12, 2026, 17:31 UTC